시장보고서
상품코드
1623694

세계의 호르몬 대체 요법 시장 - 규모, 점유율, 성장 분석 : 치료 유형별, 적응증별, 지역별 산업 예측(2025-2032년)

Hormone Replacement Therapy Market Size, Share, Growth Analysis, By Therapy Type, By Indication, By Region - Industry Forecast 2025-2032

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 165 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

호르몬 대체 요법(HRT) 세계 시장 규모는 2023년 289억 7,000만 달러로 평가되었고, 2024년 312억 3,000만 달러에서 2032년에는 563억 5,000만 달러로 성장해 예측기간(2025- 2032년)의 CAGR은 7.8%로 성장할 전망입니다.

호르몬 대체 요법(HRT) 시장은 주로 홍조 및 골다공증 위험과 같은 폐경기 관련 증상의 치료에서 오랜 효능으로 현저한 성장을 이루고 있습니다. 대다수는 남성을 포함한 다양한 연령층에 영향을 미치는 다른 호르몬 관련 질환에 대한 인식과 유병률 증가가 더욱 박차를 가하고 있습니다. 미국 갑상선 협회는 미국인의 12%가 평생 동안 갑상선 질환을 경험한다고 보고하고 있습니다. COVID-19 감염과 사망의 위험을 낮출 가능성이 시사되고 있습니다.그 결과 HRT 시장은 예측 기간 동안 견조한 확대가 예상됩니다.

목차

소개

  • 조사의 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차 데이터와 1차 데이터의 방법
  • 시장 규모 예측
  • 시장의 전제조건과 제한

주요 요약

  • 세계 시장 전망
  • 공급과 수요 동향 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인과 기회
    • 억제요인과 과제
  • Porter's Five Forces 분석

주요 시장 인사이트

  • 중요성공요인
  • 경쟁도
  • 주요 투자 기회
  • 시장 생태계
  • 시장의 매력 지수(2024년)
  • PESTEL 분석
  • 거시경제지표
  • 밸류체인 분석
  • 가격 분석
  • 규제 분석
  • 사례 연구 분석
  • 특허 분석

치료유형에 따른 세계 호르몬 대체 요법(HRT) 시장 규모 & CAGR(2025-2032년)

  • 시장 개요
  • 에스트로겐과 병용 대체 요법
  • 갑상선 호르몬 대체 요법
  • 성장 호르몬 대체 요법
  • 테스토스테론 호르몬 대체 요법

적응증에 의한 세계 호르몬 대체 요법(HRT) 시장 규모 & CAGR(2025-2032년)

  • 시장 개요
  • 폐경
  • 갑상선 기능 저하증
  • 남성 성선 기능 저하증
  • 성장 호르몬 결핍증

투여경로에 의한 세계의 호르몬 대체 요법(HRT) 시장 규모 & CAGR(2025-2032년)

  • 시장 개요
  • 경구
  • 경피
  • 비경구

유통채널에 의한 세계 호르몬 대체 요법(HRT) 시장 규모 & CAGR(2025-2032년)

  • 시장 개요
  • 병원 약국
  • 소매 약국?약국
  • 온라인 약국

세계 호르몬 대체 요법(HRT) 시장 규모 & CAGR(2025-2032년)

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 이탈리아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카
    • 기타 중동 및 아프리카

경쟁 정보

  • 상위 5개사 비교
  • 주요 기업의 시장 포지셔닝(2024년)
  • 주요 시장 기업이 채용한 전략
  • 시장의 최근 동향
  • 기업의 시장 점유율 분석(2024년)
  • 주요 기업의 기업 프로파일
  • 제품 포트폴리오 분석
  • 부문별 점유율 분석
  • 수익의 전년대비 비교(2022-2024년)

    주요 기업 프로파일

    • Eli Lilly and Company
    • Pfizer Inc.
    • Novo Nordisk A/S
    • AbbVie Inc.
    • TherapeuticsMD Inc.
    • Bayer AG
    • Mylan NV(현재 Viatris의 일부)
    • Allergan plc(현재 AbbVie의 일부)
    • Sanofi SA
    • Ferring Pharmaceuticals
    • Merck & Co. Inc.
    • Johnson & Johnson
    • Ipsen SA
    • GlaxoSmithKline plc(GSK)
    • Amgen Inc.

    결론과 권장사항

    JHS 25.01.16

    Global Hormone Replacement Therapy (HRT) Market size was valued at USD 28.97 billion in 2023 and is poised to grow from USD 31.23 billion in 2024 to USD 56.35 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

    The hormone replacement therapy (HRT) market is witnessing significant growth, primarily due to its longstanding effectiveness in treating menopause-related symptoms such as hot flashes and osteoporosis risks. This expansion is further fueled by increasing awareness and prevalence of other hormone-related conditions affecting diverse age groups, including men. The surge in thyroid disorders, with the American Thyroid Association reporting that 12% of Americans will experience thyroid disease in their lifetime, is also contributing to market growth. Long-acting human growth hormone (hGH) products are enhancing treatment options, while recent studies suggest HRT may lower the risk of COVID-19 infection and mortality. Consequently, the HRT market is poised for robust expansion during the forecast period.

    Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hormone Replacement Therapy (Hrt) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

    Global Hormone Replacement Therapy (Hrt) Market Segmental Analysis

    Global Hormone Replacement Therapy (HRT) Market is segmented by therapy type, indication, route of administration, distribution channel and region. Based on therapy type, the market is segmented into estrogen and combinations replacement therapy, thyroid hormone replacement therapy, growth hormone replacement therapy and testosterone hormone replacement therapy. Based on indication, the market is segmented into menopause, hypothyroidism, male hypogonadism and growth hormone deficiency. Based on route of administration, the market is segmented into oral, transdermal and parenteral. Based on distribution channel, the market is segmented into hospitals pharmacies, retail pharmacies & drug stores and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

    Driver of the Global Hormone Replacement Therapy (Hrt) Market

    The global Hormone Replacement Therapy (HRT) market is driven by a pressing need for effective treatments among diverse patient groups, including those facing growth hormone deficiencies, menopausal symptoms in women, and hypogonadism in older men. This medication is available in various forms such as skin and buccal patches, injections, and tablets, which enhances accessibility for patients. As demand surges worldwide, manufacturers are prioritizing the development of innovative drug delivery systems, including transdermal estrogen patches and vaginal estrogen tablets. In response to safety concerns, there is a growing emphasis on low-dose estrogen therapy, alongside new gel-based formulations for estrogen patches and other delivery methods.

    Restraints in the Global Hormone Replacement Therapy (Hrt) Market

    The Global Hormone Replacement Therapy (HRT) market faces several restraints that may hinder its growth. Various treatment formulations, including patches, gels, capsules, and injections, are available; however, their potential side effects can be a significant deterrent. Issues such as elevated cholesterol levels, blood clots, bloating, and swelling can negatively impact patient perception and adoption. Furthermore, testosterone replacement therapy has been linked to adverse effects including benign prostatic hyperplasia, obstructive sleep apnea, and an increased risk of prostate cancer. The US FDA's concerns regarding the approved indications and the rising cardiovascular risks associated with testosterone products add another layer of complication that may impede market expansion.

    Market Trends of the Global Hormone Replacement Therapy (Hrt) Market

    The Global Hormone Replacement Therapy (HRT) market is witnessing a significant upward trend, fueled by rising demand in emerging nations and heightened awareness of hormone-related health issues. As more individuals recognize the benefits of HRT, pharmaceutical companies are innovating to develop advanced medications that cater to this unmet need. Notably, the aging population and increasing prevalence of menopause and associated hormone deficiencies in key markets are driving manufacturers to unveil novel product offerings, including combination therapies that enhance efficacy and patient compliance, moving away from traditional long-acting parenteral options. This evolution underscores the dynamic nature of the HRT sector.

    Table of Contents

    Introduction

    • Objectives of the Study
    • Scope of the Report
    • Definitions

    Research Methodology

    • Information Procurement
    • Secondary & Primary Data Methods
    • Market Size Estimation
    • Market Assumptions & Limitations

    Executive Summary

    • Global Market Outlook
    • Supply & Demand Trend Analysis
    • Segmental Opportunity Analysis

    Market Dynamics & Outlook

    • Market Overview
    • Market Size
    • Market Dynamics
      • Drivers & Opportunities
      • Restraints & Challenges
    • Porters Analysis
      • Competitive rivalry
      • Threat of substitute
      • Bargaining power of buyers
      • Threat of new entrants
      • Bargaining power of suppliers

    Key Market Insights

    • Key Success Factors
    • Degree of Competition
    • Top Investment Pockets
    • Market Ecosystem
    • Market Attractiveness Index, 2024
    • PESTEL Analysis
    • Macro-Economic Indicators
    • Value Chain Analysis
    • Pricing Analysis
    • Regulatory Analysis
    • Case Study Analysis
    • Patent Analysis

    Global Hormone Replacement Therapy (HRT) Market Size by Therapy Type & CAGR (2025-2032)

    • Market Overview
    • Estrogen and Combinations Replacement Therapy
    • Thyroid Hormone Replacement Therapy
    • Growth Hormone Replacement Therapy
    • Testosterone Hormone Replacement Therapy

    Global Hormone Replacement Therapy (HRT) Market Size by Indication & CAGR (2025-2032)

    • Market Overview
    • Menopause
    • Hypothyroidism
    • Male Hypogonadism
    • Growth Hormone Deficiency

    Global Hormone Replacement Therapy (HRT) Market Size by Route Of Administration & CAGR (2025-2032)

    • Market Overview
    • Oral
    • Transdermal
    • Parenteral

    Global Hormone Replacement Therapy (HRT) Market Size by Distribution Channel & CAGR (2025-2032)

    • Market Overview
    • Hospitals Pharmacies
    • Retail Pharmacies & Drug Stores
    • Online Pharmacies

    Global Hormone Replacement Therapy (HRT) Market Size & CAGR (2025-2032)

    • North America (Therapy Type, Indication, Route Of Administration, Distribution Channel)
      • US
      • Canada
    • Europe (Therapy Type, Indication, Route Of Administration, Distribution Channel)
      • Germany
      • Spain
      • France
      • UK
      • Italy
      • Rest of Europe
    • Asia Pacific (Therapy Type, Indication, Route Of Administration, Distribution Channel)
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia-Pacific
    • Latin America (Therapy Type, Indication, Route Of Administration, Distribution Channel)
      • Brazil
      • Rest of Latin America
    • Middle East & Africa (Therapy Type, Indication, Route Of Administration, Distribution Channel)
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa

    Competitive Intelligence

    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2024
    • Strategies Adopted by Key Market Players
    • Recent Developments in the Market
    • Company Market Share Analysis, 2024
    • Company Profiles of All Key Players
      • Company Details
      • Product Portfolio Analysis
      • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

    Key Company Profiles

    • Eli Lilly and Company
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Pfizer Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Novo Nordisk A/S
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • AbbVie Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • TherapeuticsMD Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Bayer AG
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Mylan N.V. (now part of Viatris)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Allergan plc (now part of AbbVie)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Sanofi S.A.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Ferring Pharmaceuticals
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Merck & Co. Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Johnson & Johnson
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Ipsen S.A.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • GlaxoSmithKline plc (GSK)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Amgen Inc.
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments

    Conclusion & Recommendations

  • 샘플 요청 목록
    0 건의 상품을 선택 중
    목록 보기
    전체삭제